Elucidation of PEGylation site with a combined approach of in-source fragmentation and CID MS/MS

Xiaojun Lu1, P Clayton Gough, Michael R DeFelippis

  • 1Bioproduct Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.